🇺🇸 Rivoroxaban in United States

10 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 20 April 2025 – 20 April 2026
• Total reports: 10

Most-reported reactions

1. Anaemia — 1 report (10%)
2. Aneurysm Ruptured — 1 report (10%)
3. Asthenia — 1 report (10%)
4. Carotid Artery Aneurysm — 1 report (10%)
5. Dermatitis Allergic — 1 report (10%)
6. Haematuria — 1 report (10%)
7. Infective Aneurysm — 1 report (10%)
8. Leukopenia — 1 report (10%)
9. Off Label Use — 1 report (10%)
10. Rash Erythematous — 1 report (10%)

Source database →

Frequently asked questions

Is Rivoroxaban approved in United States?

Rivoroxaban does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Rivoroxaban in United States?

Foundation University Islamabad is the originator. The local marketing authorisation holder may differ — check the official source linked above.